Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Launched by ADVANCING CLINICAL THERAPEUTICS GLOBALLY FOR HIV/AIDS AND OTHER INFECTIONS · Aug 30, 2001
Trial Information
Current as of January 15, 2025
Completed
Keywords
ClinConnect Summary
A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1. Using data from present and recently completed studies, this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication.
No treatment is provided by this study, but patients will continue to receive highly active antiretroviral therapy (HAART) from other studies in which they are coenrolled. Blood and urine collection will occur at study entry and...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • HIV-1 infected
- • Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this study on or before the Week 16 visit of the parent study, including the visit window of the parent study. More information on this criterion can be found in the protocol.
- • Willing to provide consent for the release and use of clinical data from the parent study
- • Life expectancy of at least 24 weeks
- • Parent or guardian willing to provide informed consent, if applicable
- • Exclusion Criteria
- • Active alcohol or drug abuse that may interfere with the study
Trial Officials
Constance A. Benson, MD
Study Chair
Division of Infectious Disease, Antiviral Research Center, University of California, San Diego
Ann C. Collier, MD
Study Chair
University of Washington
About Advancing Clinical Therapeutics Globally For Hiv/Aids And Other Infections
Advancing Clinical Therapeutics (ACT) is a global clinical trial sponsor dedicated to the development and advancement of innovative therapies for HIV/AIDS and other infectious diseases. With a commitment to improving patient outcomes, ACT conducts rigorous clinical research that adheres to the highest ethical standards and regulatory guidelines. Our multidisciplinary team collaborates with healthcare professionals, researchers, and stakeholders worldwide to facilitate the discovery and validation of effective treatments, aiming to enhance the quality of life for individuals affected by these conditions. Through our efforts, we strive to contribute significantly to the global fight against infectious diseases, fostering a healthier future for communities around the world.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Birmingham, Alabama, United States
Los Angeles, California, United States
Indianapolis, Indiana, United States
Indianapolis, Indiana, United States
New York, New York, United States
New York, New York, United States
New York, New York, United States
Columbus, Ohio, United States
West Columbia, South Carolina, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
San Diego, California, United States
Chicago, Illinois, United States
New York, New York, United States
New York, New York, United States
Rochester, New York, United States
Chapel Hill, North Carolina, United States
San Jose, California, United States
Stanford, California, United States
Stanford, California, United States
Torrance, California, United States
Washington, District Of Columbia, United States
Miami, Florida, United States
Honolulu, Hawaii, United States
Boston, Massachusetts, United States
Omaha, Nebraska, United States
Buffalo, New York, United States
Greensboro, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Philadelphia, Pennsylvania, United States
San Juan, , Puerto Rico
Charlotte, North Carolina, United States
Los Angeles, California, United States
Durham, North Carolina, United States
Pittsburgh, Pennsylvania, United States
Minneapolis, Minnesota, United States
Denver, Colorado, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
St Louis, Missouri, United States
Boston, Massachusetts, United States
Baltimore, Maryland, United States
Iowa City, Iowa, United States
New Orleans, Louisiana, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Indianapolis, Indiana, United States
Nashville, Tennessee, United States
Los Angeles, California, United States
Menlo Park, California, United States
San Rafael, California, United States
New York, New York, United States
New York, New York, United States
Seattle, Washington, United States
Rochester, New York, United States
Dallas, Texas, United States
Tripler Amc, Hawaii, United States
Denver, Colorado, United States
Camden, New Jersey, United States
Bronx, New York, United States
Portland, Oregon, United States
Houston, Texas, United States
Sacramento, California, United States
San Francisco, California, United States
Baltimore, Maryland, United States
Detroit, Michigan, United States
Minneapolis, Minnesota, United States
Newark, New Jersey, United States
Rochester,, New York, United States
Chapel Hill, North Carolina, United States
Cleveland, Ohio, United States
Norristown, Pennsylvania, United States
Dallas, Texas, United States
Richmond, Virginia, United States
San Juan,, , Puerto Rico
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials